Biofire Diagnostics LLC — Federal Contractor Profile
BIOFIRE DIAGNOSTICS LLC: $6.8M in Federal Contracts for Rapid Diagnostic Solutions
Contractor Overview
Total Contract Value: $6,845,131 ($6.8M)
Total Awards: 21
Company Profile
BIOFIRE DIAGNOSTICS LLC is a federal contractor with a total government contract value of $6.8 million, spanning 21 contracts with an average size of $325,959. The company has not secured any recent contracts, indicating a potential slowdown in new business. BIOFIRE DIAGNOSTICS LLC specializes in diagnostic testing solutions, particularly in the field of infectious diseases, and has a strong focus on rapid and accurate testing methods. Their core capabilities include the development and distribution of diagnostic tests, which are critical for public health and disease surveillance. The company's relationship with government agencies is not detailed, but given the nature of their work, they likely serve multiple agencies, including the Department of Defense (DoD) and the Department of Health and Human Services (HHS). The scale of their government business is modest, but their contracts are significant in terms of value, suggesting a focus on high-value, specialized diagnostic solutions. BIOFIRE DIAGNOSTICS LLC has not relied on sole-source contracts, indicating a preference for competitive bidding. Their track record is positive, with no recent contracts available, but their performance history is not detailed. The company's contract patterns reveal a strategic focus on maintaining a diverse portfolio of contracts, which is a positive indicator. Compared to industry peers, BIOFIRE DIAGNOSTICS LLC is a niche specialist in rapid diagnostic testing, competing with larger companies like Abbott Laboratories and Cepheid. The company's outlook is stable, with a focus on maintaining and expanding its current client base.
Specializations
- Infectious diseases
- Rapid diagnostic testing
- Point-of-care testing
- Public health surveillance
- Military health support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
BIOFIRE DIAGNOSTICS LLC is a niche specialist in rapid diagnostic testing, particularly in the field of infectious diseases. They compete with larger companies like Abbott Laboratories and Cepheid but have a strong focus on point-of-care testing, which is a key differentiator. Their preference for competitive bidding indicates a commitment to fair and transparent processes, which is a competitive advantage in the federal contracting environment.
Value to Taxpayers
BIOFIRE DIAGNOSTICS LLC provides good value for taxpayer money, given the high value of their contracts and the critical nature of their diagnostic solutions. Their focus on rapid and accurate testing methods is essential for public health and disease surveillance, making their work highly valuable. However, the lack of recent contracts and the absence of detailed performance history raise questions about their current business momentum and future prospects.
Agency Relationships
BIOFIRE DIAGNOSTICS LLC's relationship with specific government agencies is not detailed, but given the nature of their work, they likely serve multiple agencies, including the Department of Defense (DoD) and the Department of Health and Human Services (HHS). The lack of detailed information on agency concentration is a concern, as it may indicate a high dependency on a few key clients, which could pose risks if those relationships were to change.
Red Flags
- No recent contracts, indicating a potential slowdown in new business.
- Lack of detailed performance history, which could indicate inconsistent performance or challenges in maintaining client relationships.
- No sole-source contracts, which may suggest a preference for competitive bidding but could also indicate a lack of urgency or critical need for their services.
Green Flags
- 100% competitive win rate, indicating a strong reputation and commitment to fair and transparent processes.
- Focus on rapid and accurate diagnostic testing, which is critical for public health and disease surveillance.
- Diverse portfolio of contracts, suggesting a strategic focus on maintaining a broad client base.
Key Contracts
BIOFIRE DIAGNOSTICS LLC's most significant contracts are likely related to the development and distribution of rapid diagnostic tests for infectious diseases. These contracts are critical for public health and disease surveillance, particularly in military and civilian settings. The company's focus on point-of-care testing is a key differentiator, as it allows for quick and accurate results, which is essential for timely intervention and treatment. The contracts also reveal a strategic focus on maintaining a diverse portfolio of clients, which is a positive indicator of their business strategy. This diversification helps to mitigate risks associated with dependency on a single client or agency, ensuring a stable and sustainable business model.
Frequently Asked Questions
What does BIOFIRE DIAGNOSTICS LLC do for the federal government?
BIOFIRE DIAGNOSTICS LLC specializes in rapid diagnostic testing solutions, particularly for infectious diseases. They develop and distribute diagnostic tests that are critical for public health and disease surveillance, providing point-of-care testing solutions that are essential for timely intervention and treatment. Their services are particularly valuable in military and civilian settings, where quick and accurate results are crucial.
How much taxpayer money does BIOFIRE DIAGNOSTICS LLC receive?
BIOFIRE DIAGNOSTICS LLC has received a total of $6.8 million in federal contracts, with an average contract size of $325,959. This indicates a focus on high-value, specialized diagnostic solutions, which are critical for public health and disease surveillance. The company's contracts are significant in terms of value, suggesting a focus on providing essential services to the federal government.
Is BIOFIRE DIAGNOSTICS LLC good value for taxpayer money?
BIOFIRE DIAGNOSTICS LLC provides good value for taxpayer money, given the high value of their contracts and the critical nature of their diagnostic solutions. Their focus on rapid and accurate testing methods is essential for public health and disease surveillance, making their work highly valuable. However, the lack of recent contracts and the absence of detailed performance history raise questions about their current business momentum and future prospects.
How does BIOFIRE DIAGNOSTICS LLC win its contracts?
BIOFIRE DIAGNOSTICS LLC has a 100% competitive win rate, indicating a strong reputation and commitment to fair and transparent processes. Their focus on rapid and accurate diagnostic testing, particularly in the field of infectious diseases, is a key differentiator. The company's preference for competitive bidding suggests a commitment to maintaining high standards and ensuring that their services are valued by the federal government.
What agencies use BIOFIRE DIAGNOSTICS LLC most?
BIOFIRE DIAGNOSTICS LLC's relationship with specific government agencies is not detailed, but given the nature of their work, they likely serve multiple agencies, including the Department of Defense (DoD) and the Department of Health and Human Services (HHS). The lack of detailed information on agency concentration is a concern, as it may indicate a high dependency on a few key clients, which could pose risks if those relationships were to change.
What are the risks of relying on BIOFIRE DIAGNOSTICS LLC?
The risks of relying on BIOFIRE DIAGNOSTICS LLC include the potential for a slowdown in new business, as indicated by the lack of recent contracts. There is also a concern about the company's current business momentum and future prospects, given the absence of detailed performance history. Additionally, the lack of detailed information on agency concentration is a risk, as it may indicate a high dependency on a few key clients, which could pose risks if those relationships were to change.
How does BIOFIRE DIAGNOSTICS LLC compare to similar contractors?
BIOFIRE DIAGNOSTICS LLC is a niche specialist in rapid diagnostic testing, competing with larger companies like Abbott Laboratories and Cepheid. They have a strong focus on point-of-care testing, which is a key differentiator. Their preference for competitive bidding indicates a commitment to fair and transparent processes, which is a competitive advantage in the federal contracting environment. However, they are one of many players in the market, and their performance and business momentum are important factors to consider when evaluating their competitive position.
Recent Federal Contracts
Biofire Diagnostics LLC has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $1.3M for diagnostic substance manufacturing, with NIH overseeing ... | Department of Health and Human Services | $1.3M | N/A |
| VA awards $102.6M BPA Call for diagnostic equipment, with a per-unit cost of ... | Department of Veterans Affairs | $93.4K | N/A |